Publications by authors named "Anouk Claessens"

Claim this Profile
T
Therapeutic Efficacy of Adipose Tissue-Derived Components in Neuropathic Pain: A Systematic Review.
Anouk A E Claessens, Linda Vriend, Zachri N Ovadja, Martin C Harmsen, Joris A van Dongen

Bioengineering (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A long-term follow up of the laparoscopically harvested free omental flap for breast reconstruction.
Anouk A E Claessens, Martijn A van Onna, Sabrina Maaskant, Coralien L Broekhuysen

Microsurgery· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A bleeding tumor on the scalp].
Anouk K M Claessens, Jos G U Ridderbeks

Ned Tijdschr Geneeskd· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancer.
Anouk K M Claessens, Jan J V Busschbach, Bram L T Ramaekers, Frans L G Erdkamp, Jeanette M Bouma

Acta Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Patient-Reported Outcome Measures in the Surgical Treatment of Hidradenitis Suppurativa: A Systematic Review.
Anouk A E Claessens, Tert C van Alphen, Oren Lapid, Maarten M Hoogbergen, Zachri N Ovadja

Dermatol Surg· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in a real-world cohort of advanced breast cancer patients: a study of the SONABRE Registry.
Anouk K M Claessens, Bram L T Ramaekers, Dorien J A Lobbezoo, Roel J W van Kampen, Maaike de Boer

Qual Life Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of chemotherapy in treatment of advanced breast cancer: an overview for clinical practice.
Anouk K M Claessens, Khava I E Ibragimova, Sandra M E Geurts, Monique E M M Bos, Frans L G Erdkamp

Crit Rev Oncol Hematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer.
Anouk K M Claessens, Frans L G Erdkamp, Marta Lopez-Yurda, Jeanette M Bouma, Jeany M Rademaker-Lakhai

Acta Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer.
Anouk K M Claessens, Reinier Timman, Jan J Busschbach, Jeanette M Bouma, Jeany M Rademaker-Lakhai

Breast Cancer Res Treat· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conduction disorders and impact on survival after sutureless aortic valve replacement compared to conventional stented bioprostheses.
Ka Yan Lam, Ferdi Akca, Niels J Verberkmoes, Carola van Dijk, Anouk Claessens

Eur J Cardiothorac Surg· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG).
Anouk K M Claessens, Monique E M M Bos, Marta Lopez-Yurda, Jeanette M Bouma, Jeany M Rademaker-Lakhai

Breast Cancer Res Treat· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis